Table 3.
Medium | Osmolarity (mosmol kg−1) | TreA activity (U [mg protein]−1)a |
Intracellular glycine betaine pool (mM)b | |
---|---|---|---|---|
Without glycine betaine | With glycine betaine (1 mM) | |||
SMM | 356 | 55 ± 6 | 12 ± 1 | 126 ± 1 |
SMM with 0.68 M glycerol | 1,100 | 62 ± 10 | 20 ± 2 | 162 ± 33 |
SMM with 0.4 M NaCl | 1,188 | 251 ± 17 | 25 ± 2 | 304 ± 78 |
SMM with 0.4 M KCl | 1,178 | 246 ± 33 | 25 ± 3 | 299 ± 5 |
SMM with 0.61 M lactose | 1,143 | 987 ± 73 | 68 ± 11 | 776 ± 67 |
SMM with 0.62 M sucrose | 1,118 | 947 ± 87 | 63 ± 13 | 785 ± 89 |
Cells of the opuA-treA fusion strain MBB9 were grown to the mid-exponential-growth phase (OD578, approximately 1) in SMM alone or SMM with increased osmolarities that were generated by the addition of the indicated ionic or nonionic osmolyte.
Cultures of strain RMKB30 (OpuA+ OpuC− OpuD−) were grown to the mid-exponential-growth phase (OD578, approximately 1) in SMM alone or SMM with increased osmolalities in the presence of 1 mM glycine betaine spiked with 0.64 μM radiolabeled [1-14C]glycine betaine.